Global CAR T Cell Therapy Market Forecast to 2024-2035 The latest drafted document on the global CAR T Cell Therapy Market by Roots Analysis, provides a brief discussion on industry size, current growth scenario and future opportunities. In the market study report, our authors extensively covered qualitative and quantitative analysis including investment opportunities to help stakeholders in...

Cancer therapeutics continue to be one of the most active areas, in terms of drug development, there is still a significant unmet need in this domain. In fact, conventional cancer treatments, such as chemotherapy, surgery and radiation therapy, have demonstrated very limited efficacy in late-stage cancers. The global CAR T-cell therapy market size is projected to grow from USD 4.6...

Polaris Market Research has published a new report titled CAR-T Cell Therapy Market Size, Share, Trends, Industry Analysis Report: By Indication, Target Antigen [CD19/CD22, BCMA (B-Cell Maturation Antigen), and Others], and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034 that delivers up-to-date analysis with...

Polaris Market Research has introduced the latest market research report titled Dry Eyes Disease Market Size, Share, Trends, Industry Analysis Report By Drug Type (Tear-stimulating, Artificial Tears, Topical Corticosteroids, Immunosuppressive, and Others), By Technology, By Distribution Channel, and By Region -Market Forecast, 2025 - 2034 that highlights the major revenue stream for...

Market Overview The global anti-crease agent market was valued at USD 782.8 million in 2021 and is expected to reach USD 1,203.6 million by 2030, growing at a CAGR of 5.1%. Anti-crease agents, a critical segment of textile finishing agents, are used to enhance the wrinkle resistance, durability, and aesthetic appeal of fabrics. As consumer demand...

The global gout therapeutics market is poised for significant expansion over the next decade. Valued at USD 3.13 billion in 2024, the market is projected to grow at a compound annual growth rate (CAGR) of 7.0% from 2025 to 2034, reaching USD 6.15 billion by 2034. The increasing prevalence of gout, advancements in therapeutic options, and heightened awareness of...